Antibody Formation in COVID-19 and Immunisation
Download Citation in txt
Download Citation in bib
Download Citation in ris
Corresponding AuthorJames Pandarakalam
Northwest Boroughs Healthcare NHS Foundation Trust, Hollins Park Hospital & AFG Rehab Hospitals, Winwick, Warrington, UK
A B S T R A C T
Antibody testing is vital in the study of the dangerousness, spread, identification of high-risk individuals and vaccine production against SARS-CoV-2. Viruses leave trails in the infected body and the immunologists turn out to be the detectives examining these viral footprints. There are two major types of tracks or memory responses that can be utilized by the body against reinfection: B cells which produce antibodies and T cells organising responses through cytotoxic cells and restricting viral replication. T cells’ memory of SARS-CoV-2 appears to last longer than antibodies and immunisation can activate T cells as well if it fails to induce long term antibody production. The immune history of SARS-CoV-2 is a huge jigsaw puzzle; several pieces are still missing. This viral research has met with a shortage of valuable foundational knowledge because of the sudden appearance of the virus and its spread. COVID-19 has posed an existential problem for the whole of human society.
Article TypeReview Article
Publication historyReceived: Mon 20, Jul 2020
Accepted: Mon 03, Aug 2020
Published: Sat 08, Aug 2020
Copyright© 2023 James Pandarakalam. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.